DNLI · Company research
Denali Therapeutics Inc. (DNLI): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 19.16 | $3,834,327,835.47 | 3632797835.47 | 37.4038461538461538 | — | — | 1063.9089443590455050 | 4.5910306970130918 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.